Vascular endothelial growth factor +936 C/T gene polymorphism and glioma risk in a Chinese Han population.
Angiogenesis plays an important role in tumor progression. The vascular endothelial growth factor (VEGF) is an important regulator of angiogenesis. The objective of this study was to investigate the association between VEGF +936 C/T gene polymorphism and glioma risk in a Chinese Han population. We extracted the peripheral blood samples in 160 glioma patients and 320 controls. Genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism method. Glioma patients had a significantly higher frequency of TT genotype (odds ratio [OR] = 3.75, 95% confidence interval [CI] = 1.24, 11.40; p = 0.02) than controls. Glioblastoma patients had a significantly higher frequency of TT genotype (OR = 3.05, 95% CI = 1.11, 8.37; p = 0.03) than other gliomas. Patients with grade IV glioma had a significantly higher frequency of TT genotype (OR = 3.12, 95% CI = 1.14, 8.58; p = 0.03) than low-grade glioma. Our study indicated that VEGF + 936 C/T genotype was associated with a higher glioma risk in a Chinese Han population.